Variant report
Variant | esv1823035 |
---|---|
Chromosome Location | chr6:27283254-27289249 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:27)
- CpG islands (count:0)
- Chromatin interactive region (count:13)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:27 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr6:27285617-27285993 | K562 | blood: | n/a | n/a |
2 | BHLHE40 | chr6:27286829-27287040 | K562 | blood: | n/a | n/a |
3 | CEBPB | chr6:27287364-27287556 | K562 | blood: | n/a | n/a |
4 | GTF2B | chr6:27286739-27287042 | K562 | blood: | n/a | n/a |
5 | GTF2F1 | chr6:27285701-27285743 | K562 | blood: | n/a | n/a |
6 | GTF2F1 | chr6:27286939-27286948 | H1-hESC | embryonic stem cell: | n/a | n/a |
7 | HEY1 | chr6:27286713-27287207 | K562 | blood: | n/a | n/a |
8 | HEY1 | chr6:27286775-27287115 | K562 | blood: | n/a | n/a |
9 | JUN | chr6:27285393-27285543 | K562 | blood: | n/a | n/a |
10 | MAFF | chr6:27286805-27287029 | K562 | blood: | n/a | n/a |
11 | MAFK | chr6:27286831-27287006 | K562 | blood: | n/a | n/a |
12 | MAX | chr6:27285564-27285844 | K562 | blood: | n/a | n/a |
13 | MAZ | chr6:27285793-27285851 | K562 | blood: | n/a | n/a |
14 | PML | chr6:27286741-27287183 | K562 | blood: | n/a | n/a |
15 | POLR2A | chr6:27286816-27286827 | K562 | blood: | n/a | n/a |
16 | POLR2A | chr6:27286839-27287154 | K562 | blood: | n/a | n/a |
17 | POLR2A | chr6:27286712-27287246 | K562 | blood: | n/a | n/a |
18 | POLR2A | chr6:27286805-27287092 | K562 | blood: | n/a | n/a |
19 | POLR2A | chr6:27286762-27287263 | K562 | blood: | n/a | n/a |
20 | POLR2A | chr6:27286850-27286979 | H1-hESC | embryonic stem cell: | n/a | n/a |
21 | RCOR1 | chr6:27286775-27287066 | K562 | blood: | n/a | n/a |
22 | STAT3 | chr6:27283612-27283855 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | TAF7 | chr6:27286691-27287158 | K562 | blood: | n/a | n/a |
24 | TAF7 | chr6:27286833-27287047 | K562 | blood: | n/a | n/a |
25 | TAF7 | chr6:27286708-27287160 | H1-hESC | embryonic stem cell: | n/a | n/a |
26 | TEAD4 | chr6:27286664-27287212 | K562 | blood: | n/a | n/a |
27 | ZMIZ1 | chr6:27286833-27287131 | K562 | blood: | n/a | n/a |
No data |
(count:13 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:27280638..27284776-chr6:27284821..27286984,4 | K562 | blood: | |
2 | chr6:27275752..27278982-chr6:27286043..27289546,5 | K562 | blood: | |
3 | chr6:27273565..27277461-chr6:27284741..27287387,3 | K562 | blood: | |
4 | chr6:27283617..27285122-chr6:27291968..27294093,2 | K562 | blood: | |
5 | chr6:27285675..27289188-chr6:27290325..27293992,4 | K562 | blood: | |
6 | chr6:27267639..27271310-chr6:27281448..27285145,3 | K562 | blood: | |
7 | chr6:27280638..27284776-chr6:27284821..27286984,4 | K562 | blood: | |
8 | chr6:27274897..27277280-chr6:27287686..27289546,3 | K562 | blood: | |
9 | chr6:27283136..27284776-chr6:27284821..27286348,2 | K562 | blood: | |
10 | chr6:27283136..27284776-chr6:27284821..27286348,2 | K562 | blood: | |
11 | chr6:27283444..27285555-chr6:27322877..27325059,2 | K562 | blood: | |
12 | chr6:27280993..27282944-chr6:27286928..27288455,2 | K562 | blood: | |
13 | chr6:27283533..27286469-chr6:27424537..27427357,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
POM121L2 | TF binding region |
VN1R10P | TF binding region |
ENSG00000220758 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2893910 | chr6:27283254-27283255 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs2893911 | chr6:27283303-27283304 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
3 | rs565618424 | chr6:27283308-27283309 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532852001 | chr6:27283326-27283327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs73738749 | chr6:27283415-27283416 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs537178148 | chr6:27283485-27283486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs142731448 | chr6:27283515-27283516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs150593891 | chr6:27283524-27283525 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs542959137 | chr6:27283674-27283675 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
10 | rs561842210 | chr6:27283685-27283686 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs572267472 | chr6:27283726-27283727 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs139609213 | chr6:27283837-27283838 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs564300939 | chr6:27283838-27283839 | Weak transcription | TF binding regionChromatin interactive region | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs75383980 | chr6:27283866-27283867 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs34343759 | chr6:27283881-27283882 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs549941409 | chr6:27283940-27283941 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs550878494 | chr6:27283958-27283959 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs182918064 | chr6:27284067-27284068 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs116453860 | chr6:27284083-27284084 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs371243597 | chr6:27284098-27284099 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs143381581 | chr6:27284148-27284149 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs566259161 | chr6:27284167-27284168 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs146714304 | chr6:27284177-27284178 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs34394775 | chr6:27284260-27284261 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs374518262 | chr6:27284262-27284263 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs533266424 | chr6:27284351-27284352 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs371723138 | chr6:27284357-27284358 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs111698598 | chr6:27284484-27284485 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs371869938 | chr6:27284512-27284513 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs186885827 | chr6:27284550-27284551 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs73390697 | chr6:27284555-27284556 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs529590597 | chr6:27284637-27284638 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs557035995 | chr6:27284712-27284713 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs574036074 | chr6:27284721-27284722 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs536263642 | chr6:27284727-27284728 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs75941492 | chr6:27284775-27284776 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs573133400 | chr6:27284806-27284807 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs140311104 | chr6:27284828-27284829 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs564362134 | chr6:27284893-27284894 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs75270315 | chr6:27284901-27284902 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs577957410 | chr6:27284930-27284931 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs559661354 | chr6:27285019-27285020 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs191778566 | chr6:27285061-27285062 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs563248552 | chr6:27285083-27285084 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs528948900 | chr6:27285084-27285085 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs144040669 | chr6:27285153-27285154 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs185005544 | chr6:27285155-27285156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs144907996 | chr6:27285157-27285158 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs149028861 | chr6:27285177-27285178 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs571559974 | chr6:27285202-27285203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17133270 | CNVD |
Autism | 22495311 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Cancer | 16790693 | CNVD |
Breast cancer | 22032731 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21785460 | CNVD |
Retinoblastoma | 16790693 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Gastric cancer | 17908304 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 16397240 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 19571809 | CNVD |
Schizophrenia | 19571808 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:27281000-27286600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr6:27285600-27286200 | Enhancers | K562 | blood |
3 | chr6:27285800-27286000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr6:27285800-27286000 | Bivalent Enhancer | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr6:27285800-27286000 | Bivalent/Poised TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr6:27286200-27286800 | Weak transcription | K562 | blood |
7 | chr6:27286800-27287000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr6:27286800-27287000 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr6:27286800-27287000 | Enhancers | K562 | blood |